Merck & Co. has agreed to pay more than $671 million to settle a pair ofwhistleblower lawsuits that claimed the company used improper marketingtactics, including kickbacks to doctors, to encourage them to write moreprescriptions for its most profitable drugs, like Vioxx, Zocor andSingulair.
The two settlements were announced by federal prosecutors inPhiladelphia and New Orleans.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
For questions call 1-877-256-2472 or contact us at [email protected]